Bayer Goes All In With Asundexian And Pulls Two Other Factor XIa Projects

Potential Xarelto Successor Prioritized

Bayer aerial
• Source: Bayer
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business